1. A role for the androgen receptor in the treatment of male breast cancer. (February 2016) Authors: Zhu, Jason; Davis, Carter T.; Silberman, Sandra; Spector, Neil; Zhang, Tian Journal: Critical reviews in oncology/hematology Issue: Volume 98(2016) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System. Issue 6 (23rd November 2021) Authors: Kearns, James T.; Matulay, Justin T.; Anderson, William E.; Hetherington, Timothy C.; Grigg, Claud M.; Zhu, Jason; Gaston, Kris E.; Riggs, Stephen B.; Burgess, Earle F.; Clark, Peter E. Journal: Urology practice Issue: Volume 8:Issue 6(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond. Issue 1 (25th January 2018) Authors: Zhu, Jason; Armstrong, Andrew J.; Friedlander, Terence W.; Kim, Won; Pal, Sumanta K.; George, Daniel J.; Zhang, Tian Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. Issue 1 (26th March 2020) Authors: Labriola, Matthew Kyle; Zhu, Jason; Gupta, Rajan; McCall, Shannon; Jackson, Jennifer; Kong, Eric F; White, James R; Cerqueira, Gustavo; Gerding, Kelly; Simmons, John K; George, Daniel; Zhang, Tian Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Issue 7 (1st April 2021) Authors: Ledet, Elisa M.; Burgess, Earle F.; Sokolova, Alexandra O.; Jaeger, Ellen B.; Hatton, Whitley; Moses, Marcus; Miller, Patrick; Cotogno, Patrick; Layton, Jodi; Barata, Pedro; Lewis, Brian E.; Nakazawa, Mari; Zhu, Jason; Dellinger, Beth; Elrefai, Sara; Nafissi, Nellie N.; Egan, Jan B.; Shore, Neal;... Journal: Prostate Issue: Volume 81:Issue 7(2021) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer. (March 2015) Authors: Zhang, Tian; Zhu, Jason; George, Daniel J; Armstrong, Andrew J Journal: Expert opinion on pharmacotherapy Issue: Volume 16:Number 4(2015) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. Issue 10 (17th October 2022) Authors: Brown, Landon C; Zhu, Jason; Desai, Kunal; Kinsey, Emily; Kao, Chester; Lee, Yong Hee; Pabla, Sarabjot; Labriola, Matthew K; Tran, Jennifer; Dragnev, Konstantin H; Tafe, Laura J; Dayyani, Farshid; Gupta, Rajan T; McCall, Shannon; George, Daniel J; Glenn, Sean T; Nesline, Mary K; George, Saby; Zib... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Informational needs of gastrointestinal oncology patients. (7th November 2014) Authors: Papadakos, Janet; Urowitz, Sara; Olmstead, Craig; Jusko Friedman, Audrey; Zhu, Jason; Catton, Pamela Journal: Health expectations Issue: Volume 18:Number 6(2015) Page Start: 3088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Issue 3 (2nd March 2021) Authors: Brown, Landon C; Tucker, Matthew D; Sedhom, Ramy; Schwartz, Eric B; Zhu, Jason; Kao, Chester; Labriola, Matthew K; Gupta, Rajan T; Marin, Daniele; Wu, Yuan; Gupta, Santosh; Zhang, Tian; Harrison, Michael R; George, Daniel J; Alva, Ajjai; Antonarakis, Emmanuel S; Armstrong, Andrew J Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MP53-18 CONTINUED PSA SCREENING IN MEN AGED 60 YEARS AND OLDER WITH VERY LOW SERUM PROSTATE SPECIFIC ANTIGEN IN A LARGE, INTEGRATED HEALTHCARE SYSTEM. (May 2022) Authors: Kearns, James; Donahue, Erin; Bose, Rupali; Zhu, Jason; Grigg, Claud; Burgess, Earle; Gaston, Kris; Riggs, Stephen; Matulay, Justin; Clark, Peter Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗